Overview
- The Nature Genetics paper, published Monday, August 10, 2026, analyzed tumor DNA from 200 patients in Osaka and Tokyo and detected a colibactin-associated mutational signature in about half of cases.
- Colibactin is a bacterial toxin made by some strains of E. coli that leaves a distinctive DNA-damage pattern, and the study found this pattern directly damaging key tumor suppressor genes linked to colorectal cancer.
- Traces of colibactin damage were concentrated in early-onset cases, appearing in roughly 70% of cancers diagnosed before age 40, and were more common in people born after 1965, suggesting damage may begin in childhood.
- Authors propose a hypothesis that rising antibiotic use in Japan during the 1960s–70s could have altered gut bacteria and influenced cohort risk, but they emphasize this idea is unproven and needs epidemiologic and microbiological follow-up.
- The findings strengthen Japan-specific evidence following a smaller 2025 international report and raise the prospect of microbiome-based prevention, screening, or decolonization strategies, while noting causal links and public-health value remain to be established.